| SN. |
Smith & Nephew
|
FTSE 100 |
2.21 |
£10.99B |
1,267.00 |
-2.05% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.23 |
£4.44B |
225.60 |
-0.70% |
| UPR |
Uniphar
|
AIM |
0.01 |
£908.04M |
348.00 |
0.90% |
| SPI |
Spire Healthcare Group
|
FTSE 250 |
1.13 |
£813.57M |
204.00 |
0.99% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.24 |
£468.25M |
217.00 |
3.10% |
| NIOX |
Niox Group
|
AIM |
1.89 |
£275.84M |
66.00 |
% |
| TSTL |
Tristel
|
Main Market |
3.32 |
£204.86M |
427.50 |
1.60% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£107.99M |
25.00 |
1.00% |
| SDI |
SDI Group
|
AIM |
|
£85.73M |
82.00 |
-1.50% |
| CREO |
Creo Medical Group
|
AIM |
|
£71.44M |
17.75 |
-0.80% |
| SPEC |
Inspecs Group
|
AIM |
|
£71.17M |
70.00 |
-0.30% |
| KMK |
Kromek Group
|
AIM |
|
£62.89M |
9.60 |
8.70% |
| NCYT |
Novacyt SA
|
AIM |
|
£24.21M |
34.45 |
4.20% |
| FAB |
Fusion Antibodies
|
AIM |
|
£20M |
16.00 |
25.90% |
| COG |
Cambridge Cognition Holdings
|
AIM |
|
£16.33M |
39.00 |
-0.40% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£15.24M |
17.00 |
0.60% |
| RUA |
RUA Life Sciences
|
AIM |
|
£9M |
14.50 |
-6.90% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.2M |
0.45 |
-2.30% |
| GENI |
Genincode
|
AIM |
|
£3.53M |
1.15 |
1.40% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| PYC |
Physiomics
|
AIM |
|
£1.59M |
0.52 |
-3.80% |
| TLY |
Totally
|
AIM |
|
– |
0.24 |
-1.90% |
| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |
| TRLS |
Trellus Health
|
AIM |
|
– |
0.55 |
7.30% |